A Case Report of COVID-19 in Yemen: Detailed Clinical Observations

dc.contributor.authorAlakhali, Khaled M.
dc.contributor.authorAlshahrani, Sultan M.
dc.contributor.authorAl-Worafi, Yaser Mohammed
dc.contributor.authorIrawati, Lyna
dc.date.accessioned2026-06-17T00:22:22Z
dc.date.issued2020
dc.description.abstractCoronavirus (COVID-19) is an infectious disease caused by a newly discovered coronavirus. We reported a 59-year-old Yemeni physician who was treated at home with complaints of COVID-19 symptoms. After receiving the treatment according to the COVID-19 guidelines established in Yemen, the patient made a slow recovery from 8 May 2020 to 28 May 2020. In conclusion, COVID-19 has a complicated clinical course and poor prognosis. Nevertheless, early aggressive treatment with an appropriate protocol could improve patient outcomes. However, in COVID-19, the thyroid gland plays a role in the immune system and medical professionals should consider assessing the thyroid gland in COVID-19 cases.en_US
dc.identifier10.9734/jpri/2020/v32i2630832
dc.identifier.citationAlakhali, K. M., Alshahrani, S. M., Al-Worafi, Y. M., & Irawati, L. (2020). A case report of COVID-19 in Yemen: Detailed clinical observations.�Journal of Pharmaceutical Research International,�32(26), 1-5.�https://doi.org/10.9734/jpri/2020/v32i2630832en_US
dc.identifier.urihttps://repository.ust.edu.ye/handle/123456789/548
dc.identifier.urihttps://journaljpri.com/index.php/JPRI/article/view/1700
dc.language.isoen
dc.publisherSciencedomain Internationalen_US
dc.titleA Case Report of COVID-19 in Yemen: Detailed Clinical Observationsen_US
dc.typeArticleen_US

ملفات